Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Will KT Corporation KT stock drop more today Q4 2025 EPS Exceeds Expectations Virtus VGI Stock PEG Ratio Bullish Sentiment 20260418 AMCR Amcor plc Ordinary Shares reports narrow Q1 2026 EPS miss climbs 438 percent on upbeat investor sentiment Kinder Morgan Inc KMI US Online Youth Safety Legislative Push and Tech Sector Regulatory Risk AGNC AGNC Invest Q1 2026 EPS tops analyst estimates pushing shares 147 percent higher in todays trading DaVita Inc DVA Q1 2026 Earnings Preview Growth Trajectory Sector Performance and Market Outlook Apts Corp BRT Reports Strong Q1 2026 Revenue NA EPS Beats National NFG Stock Steady at 8123 Support at 7717 20260515 DEFSEC DFSC Q2 2024 Earnings Miss EPS 061 vs 053 Expected Should You Sell StoneX Group SNEX After 542 Drop 20260515 Trumps Iran Threat Berkshires Airline Bet Lululemon Proxy Battle Market Movers May 2026 Kimball Electronics KE Q1 2026 Results Miss Estimates EPS 033 vs 034 Huawei Unveils Logic Folding Chip Approach as Rivalry With Nvidia and Apple Intensifies US Jobless Claims Remain Low Signaling Persistent Labor Market Strength Israeli and Palestinian Entrepreneurs Forge CrossBorder Partnerships Amid Ongoing Conflict Intuitive Machines LUNR Faces Investor Divide Amid Space Sector Ambitions Dodgers Star Mookie Betts Calls for Increased Fan Support Amid Slump Iran Strikes Test Wall Street Optimism as Deal Talks Continue SUI Q1 2026 Earnings EPS Misses Estimates by 126 Stock Gains on Market Optimism SWBI Q1 2026 Earnings Earnings per Share Beat Estimates Revenue Details Not Provided CREX Q1 2026 Earnings EPS Falls Sharply Below Estimates Despite Positive Stock Reaction DOYU Q4 2025 Earnings Massive EPS Surprise as Company Returns to Profitability MDB Q1 2026 Earnings EPS Surprises to the Upside but Stock Slides 362 Thermo Fisher Scientific Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Stock Pullback Rani Therapeutics RANI Plunges Nearly 10 as Stock Tests Critical Support Level Extreme Networks Dips 130 as Stock Tests Key Support Levels Nuveen Municipal Value Fund NUV Steady Near 900 Amid Modest Decline Zions Bancorporation ZION Edges Higher as Regional Banking Sentiment Stabilizes Scinai Immunotherapeutics SCNI Declines 725 Eyes Key Support at 043